Literature DB >> 7681082

Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages.

M A Dentener1, V Bazil, E J Von Asmuth, M Ceska, W A Buurman.   

Abstract

CD14 has been reported to function as a receptor for bacterial LPS complexed with serum proteins, transducing an activation signal for TNF-alpha production. We found that the anti-CD14 mAb MEM-18 inhibited not only LPS-induced release of TNF-alpha, but also LPS-induced, TNF-alpha independent release of IL-6 and IL-8 by human monocytes and alveolar macrophages. Inhibitory effect of MEM-18 was detected both in the presence of human or bovine calf serum and under serum-free conditions. In contrast, MEM-18 did not block release of these cytokines induced by IL-1 beta, TNF-alpha, PMA, and zymosan. We conclude that CD14 is involved in LPS-induced release of TNF-alpha, IL-6, and IL-8 by monocytes and alveolar macrophages and that this receptor appears to be able to recognize LPS directly in the absence of serum.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7681082

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  64 in total

1.  Di-(2-ethylhexyl) phthalate induces production of inflammatory molecules in human macrophages.

Authors:  Junko Nishioka; Chihiro Iwahara; Mikiko Kawasaki; Fumiko Yoshizaki; Hitoshi Nakayama; Kenji Takamori; Hideoki Ogawa; Kazuhisa Iwabuchi
Journal:  Inflamm Res       Date:  2011-10-18       Impact factor: 4.575

2.  Peptidoglycan and lipoteichoic acid modify monocyte phenotype in human whole blood.

Authors:  P F Jørgensen; J E Wang; M Almlöf; C Thiemermann; S J Foster; R Solberg; A O Aasen
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

3.  Effects of the individual isomers cis-9,trans-11 vs. trans-10,cis-12 of conjugated linoleic acid (CLA) on inflammation parameters in moderately overweight subjects with LDL-phenotype B.

Authors:  Julian D Ramakers; Jogchum Plat; Jean-Louis Sébédio; Ronald P Mensink
Journal:  Lipids       Date:  2005-09       Impact factor: 1.880

4.  Temporal trends of circulating nitric oxide and pro-inflammatory cytokine responses ex vivo in intra-abdominal sepsis: results from a cohort study.

Authors:  Miriam Ojeda Ojeda; Hilev Larrondo Muguercia; Abel Magdariaga Figuerola; Alfredo Sánchez Valdivia; Ingrid Rodríguez Alonso; Carmen Valenzuela Silva; Elizeth García Iglesias; Emma Domínguez Alonso; Wim A Buurman; Manuel de Jesús Araña Rosaínz
Journal:  Inflamm Res       Date:  2010-10-26       Impact factor: 4.575

5.  SARS-CoV regulates immune function-related gene expression in human monocytic cells.

Authors:  Wanchung Hu; Yu-Ting Yen; Sher Singh; Chuan-Liang Kao; Betty A Wu-Hsieh
Journal:  Viral Immunol       Date:  2012-08       Impact factor: 2.257

6.  Differential regulation of IL-8 by IL-1beta and TNFalpha in hyaline membrane disease.

Authors:  K Y Kwong; C A Jones; R Cayabyab; C Lecart; C L Stotts; I Randhawa; R Ramanathan; N Khuu; P Minoo; R A deLemos
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

Review 7.  Soluble CD14: role in atopic disease and recurrent infections, including otitis media.

Authors:  Karin C Lødrup Carlsen; Berit Granum
Journal:  Curr Allergy Asthma Rep       Date:  2007-11       Impact factor: 4.806

8.  Binding of lipopolysaccharide (LPS) to an 80-kilodalton membrane protein of human cells is mediated by soluble CD14 and LPS-binding protein.

Authors:  J Schletter; H Brade; L Brade; C Krüger; H Loppnow; S Kusumoto; E T Rietschel; H D Flad; A J Ulmer
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

9.  Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne.

Authors:  B R Vowels; S Yang; J J Leyden
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

10.  CD14 expression and binding of lipopolysaccharide to alveolar macrophages and monocytes.

Authors:  T S Haugen; B Nakstad; O H Skjønsberg; T Lyberg
Journal:  Inflammation       Date:  1998-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.